近年来越来越多的科研人员开始对生物信息学感兴趣，生物信息学相关文章更是逐年上升。可慢慢的出现了“生信文章现在很难发了”的感慨和质疑，那么如何选择一本合适的期刊也变得尤其重要，今天小编就来推荐一些小编心中生信友好期刊，快来看看吧。
2002年创刊的Molecular Cancer杂志，在影响因子层面一路高歌猛进，目前IF=27.401，其主要接收靶向治疗、分子与细胞生物学、基因组学、遗传学、病理与肿瘤免疫学等领域相关的学术论文。主要以论著和综述为主，Letter数量近年略有增加。
Molecular Cancer杂志中包含了很多热点方向的生信分析文章，如RNA修饰的相关文章“Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer”；m6A的相关文章“m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer”和“Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types”；肿瘤抗原的相关文章“Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development”和“Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development”等等。
1995年创刊的Clinical Cancer Research杂志，在影响因子层面一直较为稳定，目前IF=12.531，其主要接收靶向治疗的临床与转化研究，药物敏感性和耐药性机制，遗传药理学和药物基因组学，个性化医学，生物信息学和生物统计学应用，免疫治疗和临床免疫学，人类肿瘤分子表征和诊断生物标志物等领域相关的学术论文。主要以论著为主，另包含少部分letter、review等类别文章。
Clinical Cancer Research杂志中包含了很多热点方向的生信分析文章，如免疫与预后的相关文章“An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy”和“An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma”；免疫治疗的相关文章“Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing”；单细胞数据的相关文章“Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance”和“Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment”等等。
2000年创刊的Briefings in Bioinformatics杂志，在影响因子层面稳步上升，目前IF = 11.622，其主要接收表型和基因型的遗传研究、DNA测序、代谢和信号通路、结构确定和功能预测、蛋白质组学、生信数据库和分析工具等领域相关的学术论文，与有关生信新工具、数据库和新方法居多，以及部分纯生信的分析文章。
Briefings in Bioinformatics杂志中包含了很多热点方向的生信分析文章，如免疫与预后的相关文章“Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer”和“Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response”；筛选基因标志物的相关文章“A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma”和“Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor”；可变剪切的相关文章“Comprehensive characterization of alternative splicing in renal cell carcinoma”；单细胞数据的相关文章“Comprehensive analysis of partial methylation domains in colorectal cancer based on single-cell methylation profiles”等等。
2012年创刊的OncoImmunology杂志，在影响因子层面略有降低但保持在5分以上，目前IF= 8.110，其主要接收肿瘤免疫学的转化与临床研究、癌症治疗和免疫治疗等领域相关的学术论文。主要以论著为主，其他类别文章占10-15%。
OncoImmunology杂志中包含了很多热点方向的生信分析文章，如免疫治疗的相关文章“Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma”；新抗原的相关文章“HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer”；患者生存的相关文章“Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer”和“Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma”等等。
2010年创刊的Frontiers In Immunology杂志，在影响因子层面略有波动，除2018年外基本维持在5分以上，目前IF=7.561，其主要接收同种免疫和移植、抗原提呈细胞生物学、自身免疫性疾病和自身炎症疾病、B细胞生物学、癌症免疫治疗、比较免疫学、细胞因子和免疫中的可溶性介体、免疫记忆、免疫耐受和调节、炎症、微生物免疫学、分子先天免疫、粘膜免疫、多发性硬化症和神经免疫学、NK和先天淋巴样细胞生物学、营养免疫学、原发性免疫缺陷、T细胞生物学、疫苗和分子治疗学、病毒免疫学等领域相关的学术论文。文章类型主要以论著和综述为主。
Frontiers In Immunology杂志中包含了很多热点方向的生信分析文章，如单基因泛癌分析的相关文章“A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint”；m6A、缺氧、自噬等热点内容的相关文章“Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma”、 “Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma”和“Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature”；识别预后标记物的相关文章“Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma”和“A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis”；识别分子亚型的相关文章“Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy”等等。
除了上述5个杂志，小编还将其他生信友好期刊进行了整理，对比近两年的影响因子，以便于小伙伴们选出适合自己文章的杂志。
杂志2019年IF2020年IF
Molecular Cancer15.30227.401
Cancer Research9.72712.701
Clinical Cancer Research10.10712.531
Briefings in Bioinformatics8.99011.622
Genome Medicine10.67511.117
Oncogene7.9719.867
Cell Reports8.1099.423
Cancer Letters7.3608.679
OncoImmunology5.8698.110
Ebiomedicine5.7368.143
Frontiers In Immunology5.0857.561
British Journal of Cancer5.7917.640
International Journal of Cancer5.1457.396
Bioinformatics5.6106.937
Frontiers in Cell and Developmental Biology5.1866.684
Cancers6.1266.639
Molecular Oncology6.5746.603
Genomics6.2055.757
International Journal of Oncology3.8995.650
Frontiers in Genetics3.2604.599
Cancer Medicine3.4914.452
Journal of Cellular Biochemistry4.2374.429
BMC Cancer3.1504.430
Scientific Reports3.9984.379
Journal of Cancer3.5654.207
International Journal of Molecular Medicine3.0984.101
Genes3.7594.096
BMC Genomics3.5943.969
Biochemical and Biophysical Research Communications2.9853.575
International Journal of Medical Sciences2.5233.738
BMC Bioinformatics3.2423.169
BMC Medical Genomics2.5703.063
PeerJ2.3792.984
BMC Medical Genetics1.5852.103
Genetic Testing and Molecular Biomarkers1.3781.795
Journal of Computational Biology1.0811.479
Translational Cancer Research0.9861.241
快来使用生信人开发的文献下载利器查期刊，做科研，下文献-paperneed
paperneed(https://paperneed.cn/)查文献、查期刊，为自己的工作选择一个适合的杂志吧~